Shosuke Ito Selected Research

Shosuke Ito Research Topics

Disease

30	Melanoma (Melanoma, Malignant) 06/2022 - 12/2002
12	Neoplasms (Cancer) 06/2022 - 08/2004
8	Parkinson Disease (Parkinson's Disease) 04/2022 - 08/2003
8	Skin Neoplasms (Skin Cancer) 11/2018 - 06/2002
6	Experimental Melanoma 01/2017 - 12/2002
5	Hyperpigmentation 04/2019 - 02/2003
4	Sunburn 01/2017 - 10/2004
4	Hyperthermia 06/2013 - 03/2007
2	Hypopigmentation (Hypomelanosis) 01/2022 - 01/2019
2	Obesity 01/2022 - 12/2008
2	Phototoxic Dermatitis (Phototoxicity) 05/2020 - 07/2010
2	Carcinogenesis 01/2017 - 12/2009
2	Neoplasm Metastasis (Metastasis) 09/2010 - 08/2003
2	Uveal melanoma 08/2009 - 04/2009
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2009 - 01/2007
2	Pigmented Nevus (Melanocytic Nevus) 11/2005 - 10/2004
1	Movement Disorders (Movement Disorder) 04/2022
1	Hyperphagia (Overeating) 01/2022
1	Vitiligo 07/2021
1	Contact Dermatitis (Eczema, Contact) 07/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Hyperplasia 01/2021
1	Infections 10/2020
1	Wounds and Injuries (Trauma) 10/2020
1	Inflammation (Inflammations) 01/2020
1	Albinism 01/2019
1	Eye Abnormalities (Eye Abnormality) 01/2019
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2019
1	Rupture 03/2014
1	Macular Degeneration (Age-Related Maculopathy) 05/2013

Drug/Important Bio-Agent (IBA)

23	Melanins (Melanin)IBA 06/2022 - 08/2003
10	pheomelaninIBA 01/2017 - 12/2002
9	Monophenol Monooxygenase (Tyrosinase)IBA 04/2022 - 04/2004
9	eumelaninIBA 01/2020 - 10/2004
8	Proteins (Proteins, Gene)FDA Link 05/2019 - 08/2004
5	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 09/2005
5	Free RadicalsIBA 06/2022 - 06/2005
5	Biological ProductsIBA 06/2022 - 10/2003
4	Dopamine (Intropin)FDA LinkGeneric 04/2022 - 01/2007
4	Type 1 Melanocortin ReceptorIBA 01/2020 - 08/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2002
4	Cysteine (L-Cysteine)FDA Link 01/2017 - 12/2002
4	N-propionyl-4-S-cysteaminylphenolIBA 01/2013 - 09/2010
4	Tyrosine (L-Tyrosine)FDA Link 01/2013 - 03/2007
4	AminesIBA 01/2013 - 12/2003
3	neuromelaninIBA 04/2022 - 08/2003
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2022 - 12/2008
3	rhododendrolIBA 07/2021 - 05/2015
3	ColforsinIBA 01/2020 - 04/2009
3	SulfurIBA 01/2013 - 03/2007
3	Caspase 3 (Caspase-3)IBA 07/2012 - 10/2004
3	CysteinyldopaIBA 03/2011 - 08/2003
3	Biomarkers (Surrogate Marker)IBA 03/2011 - 08/2003
3	Ferrosoferric Oxide (Magnetite)FDA Link 09/2009 - 03/2007
3	4-S-cysteaminylphenolIBA 03/2007 - 12/2003
3	4-amino-3-hydroxyphenylalanineIBA 04/2006 - 08/2003
2	EnzymesIBA 06/2022 - 03/2014
2	AntioxidantsIBA 06/2022 - 05/2020
2	Melanocyte-Stimulating Hormones (MSH)IBA 01/2022 - 01/2017
2	quinone (benzoquinone)IBA 01/2017 - 09/2012
2	Sulfhydryl Compounds (Thiols)IBA 01/2017 - 05/2015
2	Peptides (Polypeptides)IBA 01/2013 - 09/2010
2	MelanocortinsIBA 10/2010 - 09/2006
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2010 - 01/2009
2	Pyrimidine DimersIBA 07/2010 - 10/2004
2	GlypicansIBA 11/2005 - 10/2004
2	Tumor Biomarkers (Tumor Markers)IBA 11/2005 - 10/2004
2	alpha-MSHIBA 02/2003 - 06/2002
1	Pharmaceutical PreparationsIBA 06/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2022
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 04/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022
1	catechol (pyrocatechol)IBA 10/2021
1	3,4-dihydroxyphenylacetaldehydeIBA 10/2021
1	AldehydesIBA 10/2021
1	Monoamine Oxidase (MAO)IBA 10/2021
1	Skin Lightening PreparationsIBA 07/2021
1	CosmeticsIBA 07/2021
1	Singlet OxygenIBA 04/2021
1	Aldehyde DehydrogenaseIBA 04/2019
1	Ethanol (Ethyl Alcohol)IBA 04/2019
1	nitisinone (Orfadin)FDA Link 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Neutralizing AntibodiesIBA 01/2017
1	CateninsIBA 01/2017
1	Cytochalasin BIBA 03/2014
1	InflammasomesIBA 03/2014
1	Cathepsin BIBA 03/2014
1	Dextrans (Dextran)FDA Link 03/2014
1	maleimideIBA 03/2014
1	4-nitrophenoxycarbonyl methyl disulfideIBA 03/2014
1	N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA 03/2014
1	EpitopesIBA 06/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2013

Therapy/Procedure

6	Therapeutics 06/2022 - 03/2007
4	Immunotherapy 06/2022 - 01/2009
3	Drug Therapy (Chemotherapy) 06/2022 - 09/2006
2	Injections 09/2012 - 07/2012
2	Renal Dialysis (Hemodialysis) 01/2009 - 01/2007
1	Immunomodulation 06/2022